Synagis and Cardiac arrest - a phase IV clinical study of FDA data
Cardiac arrest is found among people who take Synagis, especially for people who are male, 0-1 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Synagis and have Cardiac arrest. It is created by eHealthMe based on reports of 16,708 people who have side effects when taking Synagis from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
16,708 people reported to have side effects when taking Synagis.
Among them, 166 people (0.99%) have Cardiac arrest.
What is Synagis?
Synagis has active ingredients of palivizumab. eHealthMe is studying from 16,714 Synagis users for its effectiveness, alternative drugs and more.
What is Cardiac arrest?
Cardiac arrest is found to be associated with 3,066 drugs and 2,451 conditions by eHealthMe.
Number of Synagis and Cardiac arrest reports submitted per year:
Time on Synagis when people have Cardiac arrest *:
Gender of people who have Cardiac arrest when taking Synagis*:
Age of people who have Cardiac arrest when taking Synagis *:
Common drugs people take besides Synagis *:
Common side effects people have besides Cardiac arrest *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Synagis and have Cardiac arrest?Check whether Cardiac arrest is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Cardiac arrest and when was it recovered:
Expand to all the drugs that have ingredients of palivizumab:
- Cardiac arrest and drugs with ingredients of palivizumab (139 reports)
Alternative drugs to, pros and cons of Synagis:
- Synagis (16,714 reports)
Common Synagis side effects:
- Bronchiolitis (inflammation of the membranes lining the bronchioles in lungs): 2,048 reports
- Fever: 1,747 reports
- Cough: 1,417 reports
- Pneumonia: 1,219 reports
- Death: 1,045 reports
- Breathing difficulty: 865 reports
- Nausea and vomiting: 675 reports
Browse all side effects of Synagis:a b c d e f g h i j k l m n o p q r s t u v w x y z
Cardiac arrest treatments and more:
- Cardiac arrest (93,966 reports)
COVID vaccines that are related to Cardiac arrest:
- Cardiac arrest in Moderna COVID Vaccine
- Cardiac arrest in Pfizer BioNTech Covid Vaccine
- Cardiac arrest in Johnson and Johnson Covid Vaccine
Common drugs associated with Cardiac arrest:
- Aspirin: 4,141 reports
- Alprazolam: 3,450 reports
- Furosemide: 3,366 reports
- Metformin: 3,011 reports
- Lasix: 2,868 reports
- Prednisone: 2,820 reports
- Morphine: 2,528 reports
- Lisinopril: 2,262 reports
- Avandia: 2,254 reports
- Omeprazole: 2,205 reports
All the drugs that are associated with Cardiac arrest:
- Cardiac arrest (3,066 drugs)
Common conditions associated with Cardiac arrest:
- High blood pressure: 3,634 reports
- Diabetes: 2,886 reports
- Pain: 2,007 reports
- Atrial fibrillation/flutter: 1,831 reports
- Depression: 1,790 reports
All the conditions that are associated with Cardiac arrest:
- Cardiac arrest (2,451 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on palivizumab (the active ingredients of Synagis) and Synagis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Albuterol and Echinacea Purpurea drug interaction - a minute ago
- Imodium and Erythromycin Ethylsuccinate drug interaction - a minute ago
- Menotropins and Cardio-Respiratory Distress - a minute ago
- How effective is Amphetamine Salt Combo for Attention Deficit/Hyperactivity Disorder? - a minute ago
- How effective is Amphetamine Salt Combo for Attention Deficit Hyperactivity Disorder? - a minute ago
- How effective is Celecoxib for Pain? - 2 minutes ago
- Vyvanse and Pancreatitis Acute - 2 minutes ago
- Cefuroxime Axetil and Skin Blushing/Flushing - 2 minutes ago
- Malaria and Tinnitus - 3 minutes ago
- Terazosin Hydrochloride and Angiopathy - 3 minutes ago